ARCHIVE # 4: 554 ARTICLES (NOV -SEPT 2006)
Dr. Timothy L. Vollmer


Chairman, Division of Neurology

Barrow Neurological Institute
St. Joseph's Hospital and Medical Center
My Educational Video on MS and MS Trials
Produced by www.MDhealthChannel.com
UNDER CONSTRUCTION
Visitors Since 03/2006
Click here to read messages from our MySpace Friends
HERE'S A FEW OF OUR 1,404 MySpace FRIENDS
CLICKING ON THE RED BUTTON BELOW COULD SAVE TOUR LIFE IF THERE'S A PROBLEM WITH A MS DRUG!
WE WILL SEND YOU BREAKING NEWS ON MS DRUGS IF YOU CLICK ON THE RED BUTTON BELOW.....Scroll down & read what we did last year...within 24 hours of the 1st death from Tysabri!
IMPORTANT: We filmed the video below within hours of the 1st death from Tysabri and e-mailed it to everyone who clicked the Flashing Red Button above!...WATCH THE VIDEO...THEN CLICK THE FLASHING RED BUTTON ABOVE!
Timothy L. Vollmer M.D.
Chairman, Division of Neurology
Barrow Neurological Institute
St. Joseph's Hospital and Medical Center


BARROW NEUROLOGICAL INSTITUTE'S
GRAND CANYON
RIM-RIM-HIKE


Organized by Dr. Robert F. Spetzler - Director, Barrow Neurological Institute

250 Photo-Slideshow


Click to view 1280 MS Walk photos!

"Join a trial at Barrow & receive all medication & study based procedures at no charge!"
Stan Swartz, CEO, The MD Health Channel

"WE PRODUCED THE FOLLOWING 9 VIDEOS FOR YOU!"
Simply click the "video" buttons below:

.

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore

"OUR TEAM IS WORKING ON A CURE FOR MS"
Runtime: 54 sec
Runtime: 54 sec
Susan N. Rhodes
Multiple Sclerosis Research
Barrow Neurological Institute

"'The 2006 Barrow Neurological Institute at St. Joseph's Hospital MS "Walk on the Wild Side" raised more than $460,000 with 3,500 walkers! Click on the blue link above to view photos"

Chris Uithoven
President
National Multiple Sclerosis Society
Arizona Chapter


"THE MS SOCIETY OFFERS MANY PROGRAMS TO HELP...EVERYTHING FROM PILATES & SUPPORT GROUPS TO HORSEBACK RIDING"
Jerry Turner
Program Director
National Multiple Sclerosis Society
Arizona Chapter

Previious Posts

MS NEWS ARCHIVES: by week
September 2006  
October 2006  
November 2006  
July 2013  
April 2014  

This page is powered by Blogger. Isn't yours?

Monday, November 27, 2006

 
Myelin to Blame for Many Neuropsychiatric Disorders... UCLA Department of Neurology
What makes the human brain unique? Of the many explanations that can be offered, one that doesn't come readily to mind is — myelin.

Conventional wisdom holds that myelin, the sheet of fat that coats a neuron's axon — a long fiber that conducts the neuron's electrical impulses — is akin to the wrapping around an electrical wire, protecting and fostering efficient signaling. But the research of UCLA neurology professor George Bartzokis, M.D., has already shown that myelin problems are implicated in diseases that afflict both young and old — from schizophrenia to Alzheimer's.

Now, in a report published in the journal Biological Psychiatry and available online, Bartzokis argues that the miles of myelin coating in our brain are the key "evolutionary change that defines our uniqueness as a species" and, further, may also be the cause of "our unique vulnerability to highly prevalent neuropsychiatric disorders." The paper argues that viewing the brain as a myelin-dependent "Internet" may be key to developing new and novel treatments against disease and aid in assessing the efficacy of currently available treatments, including the use of nicotine (delivered by a patch, not smoking), which may enhance the growth and maintenance of myelin.

Myelin, argues Bartzokis, who directs the UCLA Memory Disorders and Alzheimer's Disease Clinic, is "a recent invention of evolution. Vertebrates have it; invertebrates don't. And humans have more than any other species."

Bartzokis studied the reported effects of cholinergic treatments, using drugs that are known to improve a neuron's synaptic signaling in people who suffer diseases like Alzheimer's. Furthermore, he notes, some clinical and epidemiological data suggest that such treatments may modify or even delay these diseases.

Looking at such effects from a myelin-centric point of view, Bartzokis argues that cholinergic treatments may have nonsynaptic effects as well, perhaps by enhancing myelination and myelin repair — and the better the myelin, the more efficient the neuron signaling and our "Internet's" function. Specifically, such cholinergic treatments may enhance oligodendrocytes, a type of glia cell in the brain that produces myelin during the brain 's development and constantly maintains and repairs it as we age.

While more work needs to be done to fully understand the role of nonsynaptic cholinergic effects on brain development, said Bartzokis, his hypotheses can easily be tested through in vivo imaging of the brain to study the breakdown and growth of myelin. That will make it possible to directly test in humans the practical utility of the myelin-centered model of the human brain.

Ultimately, it could foster the development of novel treatments, as well as aid in assessing the efficacy of currently available treatments. These include the use of cholinergic treatments that include acetylcholinesterase inhibitors (used to treat Alzheimer's) and nicotine patches.

"Through these rather benign interventions," Bartzokis said, "such effects on the brain's vulnerable oligodendrocyte populations may offer exciting opportunities for the prevention of both developmental and degenerative brain disorders. They deserve much closer scrutiny."MORE: UCLA Department of Neurology